The OS analysis demonstrated that ORC6 expression level was as an unfavorable indicator for patients with 18 types of cancers (e.g., KIRC, KIRP and PRAD), and a protective marker only for patients with OV and THYM (Fig. 3). Here, ORC6 is linked to cancer.